Cell death-based treatment of lung adenocarcinoma.

Abstract excerpt

The most common type of lung cancer is adenocarcinoma (ADC), comprising around 40% of all lung cancer cases. In spite of achievements in understanding the pathogenesis of this disease and the development of new approaches in its treatment, unfortunately, lung ADC is still one of the most aggressive and rapidly fatal tumor types with overall survival less than 5 years. Lung ADC is often diagnosed at advanced...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immunotherapy
• Share to Models, Biological
• Share to Mutation